Translation canonically begins at a single AUG and terminates at the stop codon, generating one protein species per transcript. However, some transcripts may use alternative initiation sites or sustain translation past their stop codon, generating multiple protein isoforms. Through other mechanisms such as alternative splicing, both neurons and glia exhibit remarkable transcriptional diversity, and these other forms of post-transcriptional regulation are impacted by neural activity and disease. Here, using ribosome footprinting, we demonstrate that alternative translation is likewise abundant in the central nervous system and modulated by stimulation and disease. First, in neuron/glia mixed cultures we identify hundreds of transcripts with alternative initiation sites and confirm the protein isoforms corresponding to a subset of these sites by mass spectrometry. Many of them modulate their alternative initiation in response to KCl stimulation, indicating activity-dependent regulation of this phenomenon. Next, we detect several transcripts undergoing stop codon readthrough thus generating novel C-terminally-extended protein isoforms in vitro. Further, by coupling Translating Ribosome Affinity Purification to ribosome footprinting to enable cell-type specific analysis in vivo, we find that several of both neuronal and astrocytic transcripts undergo readthrough in the mouse brain. Functional analyses of one of these transcripts, Aqp4, reveals readthrough confers perivascular localization, indicating readthrough can be a conserved mechanism to modulate protein function. Finally, we show that AQP4 readthrough is disrupted in multiple gliotic disease models. Our study demonstrates the extensive and regulated use of alternative translational events in the brain and indicates that some of these events alter key protein properties.
Introduction
"One gene, one protein" has long been an obsolete axiom. Cells use alternative splicing, a process in which a single gene generates multiple transcripts, each of which may be translated into a protein isoform 1 . RNA-Seq studies on human cells have shown that 92-97% of multi-exon genes use alternative splicing 2, 3 . To further expand proteomic landscapes, cells can also utilize alternative initiation and termination to generate multiple protein isoforms per transcript. While alternative splicing clearly is modulated by both neural activity as well as disease states [4] [5] [6] [7] , alternative translation has not been systematically studied in the brain.
Alternative translation occurs from differences in initiation or termination on a given transcript. In conventional eukaryotic initiation, a 43S preinitiation complex scans the 5' untranslated region (UTR) until it encounters an AUG at the annotated translation initiation site (aTIS) where it is joined by the 60S ribosomal subunit to form an 80S initiation complex 8 .
However, an 80S complex may assemble at an upstream translation initiation site (uTIS) if the 5'UTR has an optimal AUG (or near-cognate NUG) or at a downstream translation initiation site (dTIS) if the aTIS is suboptimal 9 . Similarly, in conventional termination, the 80S complex concludes translation at the first in-frame stop codon. For some transcripts, however, it may read past that stop codon at some frequency and conclude translation at a second stop codon in the 3'UTR 10 . As expected, alternative initiation may generate N-terminal protein variants when in frame or entirely different protein species when out of frame, whereas stop codon readthrough can give rise to a C-terminally extended protein variants (Fig 1A) . Thus, "one transcript, one protein'' also is not a universally true axiom.
In tissues other than central nervous system (CNS), genomic and proteomic experiments have revealed a widespread use of alternative TISs [11] [12] [13] [14] [15] [16] [17] and readthrough
Results

RF of homoharringtonine-treated neuron/glia cultures reveals use of novel TISs in vitro
To investigate alternative TISs, we used mouse brain-derived primary neuron/glia mixed cultures as our experimental platform because they offer two advantages. First, such cultures can be rapidly and synchronously treated with homoharringtonine (HHT) to arrest initiating ribosomes while allowing elongating ribosomes to run off the transcript 12 . Non-neural cell cultures treated successively with HHT and cycloheximide (CHX), a drug that immobilizes elongating ribosomes 29 have been used to identify TISs previously 12 . Second, KCl treatment of neuronal cultures induces membrane depolarization, inflow of Ca2+ through L-type Ca+2 channels, and expression of c-Fos and other activity-dependent genes, thus offering a simple yet effective paradigm for studying activity-dependent gene regulation [30] [31] [32] .
Accordingly, we utilized neuron/glia cultures with or without HHT and KCl treatments and subjected them to RF following CHX treatment (Fig 1B) . Footprint distribution across transcripts revealed a near complete run-off of ribosomes from the proximal 300 nt region of the CDS following 2 minutes of HHT treatment (Fig. 1C) . To detect TISs, we focused on this 300 nt region of the most robustly expressed transcripts and developed a set of stringent criteria (see methods) to call high fidelity TISs in both KCl treated and untreated cultures. We detected TISs in 426 transcripts, most of which possessed multiple TISs, with 89.7% having two or more, and only 11.3% possessed a single TIS (Table S1 , Fig. 1D ). Although previous high-throughput studies on TISs have used non-neural cells, we compared our list of alternative TISs to published lists generated from mouse embryonic stem cells 12 or various human cells 13 and
found that more than 50% of the transcripts in our list overlapped with the lists from the previous studies. These results convinced us that RF on HHT-treated neuronal/glia culture combined with a stringent data analysis pipeline is able to detect alternative TISs in neural transcripts.
Because the number, composition and frame of TISs are important determinants of the proteomic complexity of a cell, we examined these features across the transcripts for which we detected high fidelity TISs (Fig. 1E) . On average, a transcript contained 3.18 TISs-with 1.33 uTISs, 0.94 dTIS, and 0.91 aTIS. The aTIS per transcript value of less than 1 resulted from the absence of an initiation peak at the annotated ATG in some transcripts, suggesting that these transcripts might be misannotated and that the dominant protein isoform is not the canonical one in neural cells. ATGs detected at aTISs were always in frame, indicating the robustness of our pipeline and consistent with the presence of ATG as a key contributor to the original annotation. Similarly, near cognate codons such as CTG, TTG and GTG detected at the aTISs were in frame > 99% of the time. In contrast, ATGs and cognate codons detected at uTISs and dTISs were out of frame ≥ 47% of the time. In sum, our data indicate that a brain transcript may use multiple TISs, each at a rate that is regulated in a transcript-specific manner, which can generate multiple protein variants or completely different peptide sequences.
nucleotide of Uchl1, which encodes ubiquitin C-terminal hydrolase L1, a neuron-specific deubiquitinating protease with protective roles in neurodegeneration and Alzheimer's disease 34,35 (Fig 2 A, B) . These results confirm that at least a subset of the TISs detected by our algorithm is utilized in neurons to produce detectable protein and alternative translation does contribute to the diversity in the brain proteome.
To determine if the identified alternative TISs might represent conserved and thus evolutionarily important adaptations, we next examined whether they were conserved across phyla. We used PhastCons 36 in a multi-species alignment of 60 vertebrates to compute conservation scores for the NTG codons (ATG, CTG, GTG or TTG) detected as alternative TISs, and tested the hypothesis that these were more conserved than their background sequence (the entire 5'UTRs for uTISs and the entire CDSs for dTISs). We also computed the score for the NTGs not detected as alternative TISs and the respective 5'UTRs or CDSs.
Surprisingly, regardless of alternative TISs or not and in-frame or not, 5'UTR NTGs were less conserved whereas CDS NTGs were generally more conserved than their respective backgrounds (Fig. 2C) . However, NTGs detected both as uTISs or dTISs were not more conserved than NTGs detected in their respective backgrounds. When we specifically examined the conservation of the ten alternative TISs for which we detected the corresponding peptides with LC-MS (Table 1) , we found eight of them to be highly conserved, one only moderately conserved and one not conserved (Fig. 2E) . In sum, our analyses suggest that specific alternative TISs, particularly those that are robust enough to generate detectable protein, may be highly conserved. Yet, the significantly decreased conservation of NTGs in 5'UTRs, for even many that show initiation, also suggests that some modifications of TISs may be a substrate for evolution of gene regulation across species.
Transcripts change TISs usage in response to neuronal depolarization
Neuronal activity induces de novo protein synthesis-both from existing mRNAs and via induction of a specific transcriptional program [37] [38] [39] . To profile readthrough events in our neuron/glia cultures, we used the RF dataset from HHT-untreated cultures and designed a pipeline to count the footprints mapping to the 3'UTR of robustly expressed transcripts. We carefully excluded any transcripts where alternative splicing or stop codon single nucleotide polymorphisms might give rise to such footprints (see methods for details). Overall, we identified readthrough of at least 1% in 18 transcripts (Table S2) . These include Aqp4, as well as malate dehydrogenase 1(Mdh1), but not microtubule associated protein 2(Map2) (Fig. 3A) . To independently validate the ability of these sequences to permit read-through, we cloned a cassette encompassing the distal CDS and the readthrough region of each into a dual luciferase vector so that Renilla luciferase was constitutively expressed while
Firefly luciferase was expressed only following stop codon read through 46 (Fig. 3B) .
Comparison of the relative luciferase activities confirmed that mouse Aqp4 sequence permits readthrough of 12.5% when compared to a positive control sequence where the stop codon was mutated to a sense codon (Fig. 3C) . This is a level similar to that previously reported for human Although we ruled out several other possibilities that could generate footprints mapping to the 3'UTR and corroborated sequence-mediated readthrough events with luciferase reporters, it was still possible that these events were due to the unnatural conditions of culture. In addition, in culture we cannot definitively establish which cell type is producing the readthrough event.
Therefore, we wanted to also assess alternative translation in vivo, focusing specifically on readthrough, since, unlike initiation, it does not require pharmacological manipulation in the brain. To this end, we combined RF with TRAP using mouse lines which express Green fluorescent protein (Gfp)-tagged ribosomes in either neurons (Snap25::Rpl10a-Egfp) or astrocytes (Aldh1l1::Rpl10a-Egfp), thus allowing the purification of neuronal or astrocytic ribosome-bound mRNA 47, 48 . Thus, our in vivo approach also offered readthrough discovery in a cell type-specific manner.
We subjected the Snap25::Rpl10a-Egfp and Aldh1l1::Rpl10a-Egfp brains to TRAP followed by RF, an approach we call TRAP-RF (Fig. 4A) , similar to an approach recently described by Gonzalez et al 49 .
The resulting footprints mapping to the transcriptome were highly reproducible between replicates, indicating a good reliability of the approach we have developed (Fig. 4B, C) . We confirmed enrichment of neuronal and astrocyte marker genes in , indicating we were indeed profiling ribosomes enriched from the cell types of interest (Fig. 4D) . We went on and applied the same stringent criteria as used for in vitro cultures above to detect readthrough events and identified 50 transcripts with at least 1% readthrough in the TRAP-RF data (Table S3) , and these were reproducible across
replicates. Of these, we found 21 as neuron-enriched, 19 as astrocyte-enriched, and the remaining 10 as non-cell type-specific (Fig. 4E) . Finally, we compared the in vitro and in vivo results and found that 13 out of the 18 in vitro candidates had clearly detectable readthrough in vivo as well (Fig. 4F) , including Aqp4 and Mdh1. For both in vitro and in vivo readthrough footprints, a metagene analysis revealed peaks at the first and second stop codons, consistent with the fact that translation termination is a slower process and suggesting that the footprints were indeed from ribosomes rather than of other proteins, and that the elongated peptide remained in frame (data not shown). Thus, our TRAP-RF analysis identified both cell typespecific and shared transcripts that might generate C-terminally extended protein variants owing to stop codon readthrough.
Readthrough localizes AQP4 to the perivascular region
We next wanted to test if readthrough is of functional significance. We focused on AQP4, an astrocyte membrane protein shown to have a readthrough version in other species by previous studies 28, 44 . First, to determine if a stable readthrough-extended AQP4 protein (designated AQP4X hereafter) is indeed detectable in the mouse brain, we developed a rabbit polyclonal antibody against AQP4X using a peptide from the readthrough region as an epitope. In immunofluorescence staining, the antibody recognized AQP4X but not AQP4 in cell cultures expressing the respective version of AQP4, thus demonstrating sensitivity and specificity (Fig.   S2A , B). Western blot on mouse brain lysates revealed that anti-AQP4X recognizes the expected 35 kD band in the adult brain but not in the developing brains of postnatal day 9 or younger mice (Fig. S3A ). This is interesting since astrocyte maturation, particularly the endfeet at the blood brain barrier, are not complete until 3 weeks of age 50 . In line with Western blot, immunofluorescence staining showed that AQP4X is abundant throughout the adult mouse brain (Fig. S3B ). We noted that AQP4X is significantly concentrated perivascularly, and adjacent to the endothelial cell marker PECAM-1, whereas AQP4 is also abundant farther from the blood vessels (Fig. S3B, C) . Similar results were also recently reported by others with an independently raised antibody in rats 28 . Thus, readthrough confers a conserved perivascular localization signal to AQP4.
Because commercial anti-AQP4 antibodies also recognize AQP4X, our immunofluorescence data above could not resolve if it was only AQP4X, or both AQP4X and AQP4, that is localized perivascularly. To address this, we used Adeno-associated virus 9
(AAV9) packaged with cMyc-Aqp4 (Aqp4 mRNA with an additional stop codon to prevent readthrough) under the astrocytic promotor Gfap. We reasoned that the cMyc epitope should not be detected adjacent to PECAM-1 if only AQP4 is not perivascular. Immunofluorescence staining of the transduced mouse brains showed that only about 4% of AQP4 is adjacent to PECAM-1( Fig. S3D, E) . By comparison, as evident in Fig. S3C , 75% of AQP4X is confined to the perivascular region. Thus, AQP4 mostly lies elsewhere along the astrocyte membrane, whereas AQP4X is mostly perivascular.
AQP4 is expressed in numerous tissues and required for their normal functioning 51, 52 . Therefore, we next asked if its readthrough is a brain-specific or a ubiquitous phenomenon. By immunofluorescence staining, we detected AQP4X in the retina, where it was mostly perivascular as in the brain, as well as in the kidneys. However, in contrast to the brain where staining differed from the AQP4 antibodies, in kidney the AQP4 and AQP4X expression patterns were completely overlapping (Fig. S4) . Hence, AQP4 readthrough is not a brain-specific phenomenon, however, whether it alters subcellular localization depends on the tissue.
AQP4 and AQP4X are differentially regulated by gliosis across multiple disease models
Currently it is unclear whether readthrough always occurs at a consistent rate, or if the phenomena is dynamically regulated is response to conditions in the brain. AQP4 overall has been implicated in diverse both physiological and pathophysiological processes in the brain, . We performed immunostaining for AQP4 and AQP4X in ischemic mouse brains and quantified their signals in gliotic peri-infarct regions. We found that compared to the regions on the contralesional hemisphere, GFAP-labeled peri-infarct regions showed a 2.5 fold upregulation of AQP4 but only a disproportionate 1.3 fold upregulation of AQP4X (Fig. 5A, B) . The differential increase suggested that AQP4 readthrough can be independently regulated from gene expression during pathological processes.
To determine whether this regulation was driven by the ischemia itself, or was more parsimoniously explained as part of gliosis, we next tested if another neurological disease driving reactive gliosis causes a similar differential regulation of AQP4 and AQP4X. For this we used mice lacking palmitoyl protein thioesterase-1 (PPT1), a lysosomal enzyme that is absent in human patients with infantile Batten disease
54
. PPT1-/-mice exhibit several key features of this disease, including neurodegeneration and gliosis 54, 55 . We compared the expression levels of AQP4 and AQP4X in PPT1-/-and wildtype brains using immunofluorescence staining and observed that they were indeed differentially regulated in response to gliosis in the knockout brains. While AQP4 expression was 2.5X upregulated, AQP4X was 1.5X upregulated (Fig. 
5C,D).
We finally examined if injury-induced gliosis also exerts a similar regulatory effect on AQP4 and AQP4X, simply using tissue from mice having undergone stereotactic injection, which can also induce gliosis. We marked the site of injection using AAV9 expressing cMyctagged cyan fluorescent protein (CFP) under the GFAP promoter. A robust expression of cMyc and CFP (data not shown) and mild gliosis were evident along the injected line after one month (Fig. 5E ). We then repeated the immunostaining as above and found gliotic regions to express AQP4 at ~ 3 fold and AQP4X at 1.5 fold more intensely as compared to the uninjected contralateral side (Fig. 5E, F) . Overall, our results indicate that diseases and conditions accompanied by gliosis differentially upregulate the two isoforms of AQP4 (Fig. 5G) .
Discussion
We present the first study of alternative translation in specific cell types of the CNS, and report that it is a widespread phenomena, with regulated activity and can result in alterations of protein localization and potentially function. Initially identified as viral strategies to diversify protein repertoire [56] [57] [58] , non-canonical translational events were later also reported in eukaryotes, , and is lost in Alzheimer's disease mouse models as well as human patients [66] [67] [68] . These . In addition, our MS studies were conducted on a more pure neuronal population cultured from a younger age than the RF studies, thus our MS experiment would be insensitive to astrocyte-specific proteins such as AQP4. , may continue to uncover novel roles for individual products arising from such alternative translation events.
Methods
Animal Research Committees
All procedures involving mice conformed to the Washington University institutional animal care and use committee.
Culture
Neuron/glia mix cultures from the cortices of P0 FVB mouse pups were generated as described RF RF was performed as described 12, 39 . Briefly, the cell lysates were treated with RNAseI and subjected to sucrose-cushion ultracentrifugation for pelleting monosomes. mRNA fragments were isolated from the monosomes, size-selected in a polyacrylamide, ligated to cloning linkers, and converted to cDNAs. The cDNAs were then circularized, depleted of rRNAs, PCRed and size-selected and finally deep-sequenced on Illumina Hiseq 2000 (50 bp, single end).
Ribosomal profiles of replicate cultures were highly reproducible, with Pearson's r > 0.96. to RF, on-bead RNA digestion was performed with RNAse I (Invitrogen) for 1 h with end-to-end rotation, followed by washing three times with normal-salt buffer. Small ribosomal subunits with the mRNA fragments were eluted with ribosome dissociation buffer as described (20 mM pH7.3
TRAP-RF
Tris-HCl, 250 mM NaCl, 0.5% Triton X-100, 50mM EDTA) 49 . RNA was extracted with phenolchloroform, quality-tested with Agilent BioAnalyzer, and then subjected to dephosphorylation and subsequent library preparation as described for RF above.
Analysis of Sequence Data
Culture and TRAP-RF sequencing results were quality-tested using FastQC (version 0.11.2) 77 , and one culture RF sample was removed due to low read depth. Trimmomatic (version 0.32) was used to trim low-quality bases from the ends of reads and to remove adapter sequences 78 .
Only fragments 25-35 nt in length were retained for subsequent analysis. Reads aligning to the mouse rRNA were removed using STAR (version 2.3.1z8) 79 . Surviving reads were then aligned, using bowtie2(version 2.2.2) 80 , to the mouse transcriptome (downloaded from Ensembl Release 75) after first removing degenerate sequences from the transcriptome as described 19, 81 , retaining both uniquely mapped and multi-mapped reads. Raw and analyzed data are available at GEO:
A) TIS identification
For TIS analysis on neuron/glia culture RF data, we focused on the 5'-UTR region and proximal 300bp of the CDS and excluded the downstream region where ribosome runoff after HHT treatment was not complete. In order to calculate TIS score, we first identified ribosomal P sites, which are known to exist at the 12 th , 13 th or 14 th nts of the footprints of lengths 28-29, 30-31, and 32-33 nts, respectively 17, 81 . The P site count postions were identified by using the riboSeqR package. To redress small possible errors in the P site estimation, the P site counts were smoothed by taking an average of the P site counts in a 3 nt window, one nt on each side of the initially identified P site. TIS score at every nt position on a transcript was calculated as:
Where RHHT = XHHT / NHHT * 10 and RCHX = XCHX / NCHX * 10. X is the smoothed P site count at a position, and N is the total counts in the 5'UTR and the proximal 300 nt region of the transcript.
The following procedure was used to call TISs:
(1) 10 candidate peaks were found in each transcript. The first peak was picked based on highest TIS scores. On each side of this peak, the locations were masked when finding the next peaks if: the location is less than k-bp (k=9) away from the current peak; or TIS scores keep decreasing from the current peak. The next peaks are selected the same way in the unmasked region of the transcript.
(2) Assuming that there is at least one TIS in each transcript, the first peak is always called a TIS. If a NUG codon lay within 3bp away from the called TIS, the TIS was considered overlapping and hence relocated to the position of that NUG codon.
With above criteria, only transcripts with high P-site counts at TIS locations can be used to get reliable TIS calls across samples. Requiring the peak P-sites counts of ≥32 in the considered region of a transcript in the HHT treated group for both KCl+ and KCl-, a total of 426 transcripts were kept for TIS evaluations.
B) Readthrough identification
In order to count reads aligning to non-overlapping regions for readthrough analysis in culture and TRAP-RF data, we used the BEDTools intersect command 82 . Then, similar to prior work 19 , we removed reads aligning to the following positions: 12 nts after the start codon; 15 nts before and 9 nts after the first stop codon, and 15 nts after the second stop codon. This resulted in four remaining transcriptomic regions: 5'UTR, CDS, readthrough region, and distal 3'UTR. Reads were counted in each of these regions using the uniq Unix utility.
Readthrough analysis was performed in R. Transcripts were filtered based on CDS counts as follows: in culture RF, transcripts with ≥ 320 CDS counts across all samples were retained, and in TRAP RF, transcripts with ≥ 128 CDS counts across replicates in either the Using edgeR 83 , counts were normalized to RPKM, and readthrough rate was defined for each transcript as the ratio of readthrough region RPKM to coding sequence RPKM. Next, for readthrough identification in culture RF and brain TRAP-RF datasets, transcripts with ≥ 32 readthrough region counts across samples were retained. In each dataset, surviving transcripts with ≥ 1% readthrough rate in at least 2 samples were retained for readthrough analysis. Genes with ≥ 100% readthrough or with RPKM(distal 3'UTR) ≥ RPKM(readthrough region), for any transcript isoform or in any sample, were labeled false positives and eliminated.
C) Identification of cell type-specific transcripts in TRAP-RF data
For quality assessment and filtering of TRAP-RF data, CDS counts were normalized to CPM using the edgeR package. Due to the expression of some glial transcripts in neuronal samples and vice versa, transcripts were classified as either detectable with high confidence in neurons or astrocytes or as nonspecific background, consistent with prior work 84 . Transcripts were classified as neuron-detectable by first calculating the average log2-fold-change (logFC) in expression between Aldh1l1 and Snap25 samples for genes identified as neuronal markers 85 .
Among those transcripts surviving initial CDS count filtering, transcripts with logFC greater than this average plus two standard deviations were identified as detectible in neurons with 96%
confidence. Astrocyte-detectable transcripts were identified analogously. Remaining transcripts were designated non cell-type specific.
D) Conservation analysis of uTISs and dTISs
For computing conservation scores of uTIS per transcript, phastCons format files were downloaded from UCSC Table Browser, querying the coordinates of uTIS codon from the table   of phastCons60way . Next, the average score of the three nucleotides was calculated to define the codon conservation score. Each non-uTIS NTGs in the 5'UTR was annotated using a sliding window approach, and then the codon conservation score was extracted using a similar strategy as for uTISs. These codons were further classified into in-frame and out-of-frame based on their location relative to translation start site. To test uTIS codon score with average score of 5'UTR, average score of the entire 5'UTR given transcripts with uTIS was calculated. As the score distributions appeared bimodal, Wilcoxon's rank sum test was used to test the pairwise difference.
dTISs were analyzed similarly, except that the corresponding CDSs were considered in place of the 5'UTRs.
Proteomics
A) Sample preparation
Neuronal mass spectrometry (MS) data were obtained similar to the method of Prabakaran et al. 2015 86 . In short, embryonic day 16.5 cortical neurons were cultured for 7 days (3 biological replicates) and depolarized with 55 mM potassium chloride (KCl) for 0, 15, 30, 60, 90, 120 m.
For each time point, proteins were extracted in Qproteome mammalian cell lysis buffer (Complete mini and PhosphoSTOP tablets added (Roche)) using a probe sonicator (15sec, 2x).
Protein extracts were reduced with 50 mM dithiothreitol (20 min, 56°C), alkylated with iodoacetamide (30 min, RT), diluted with 8M urea in 50mM triethyl ammonium bicarbonate (TEAB) and digested using filter aided sample preparation (FASP Protein Digestion Kit, Expedeon). Digestion was performed overnight 37°C with 2 ng/µl trypsin (Sequencing Grade
Modified Trypsin, Promega) in 50 mM TEAB and peptides were subsequently labeled on-filter using isobaric tags (TMT6plex, Thermo Fisher) according to the manufacturer's instructions.
Labeling was quenched using 5% hydroxylamine and peptides were eluted from the filters using 500 mM NaCl and acidified with 2% formic acid. 10 uL of each peptide eluate were pooled, desalted using C18 silica tips (Nestgroup) to assess labeling efficiency and to adjust sample amounts to ensure 1:1 total protein ratios across channels prior to analysis of the remaining samples. Labeled samples were mixed 1:1 and samples were desalted using Oasis HLB columns (Waters). One half of the sample volume was fractionated using high-pH HPLC fractionation on an Xbridge C18 (3.5µm) 10cm column (Waters) into 55 fractions, the other half by isoelectric focusing on off-gel pH 3-10 Immobiline Dry Strips (GE Healthcare) into 24
fractions. HPLC fractions were combined based on peptide chromatogram intensities into 22
fractions, whereas isoelectric focusing fractions were desalted using C18 silica tips (Nestgroup).
Post vacuum drying, fractions were reconstituted in sample buffer (5% formic acid, 5%
acetonitrile) for MS analysis.
B) MS analysis
Samples were analyzed on a QExactive mass spectrometer (Thermo) coupled to a microautosampler AS2 and a nanoflow HPLC pump (Eksigent). Peptides were separated using an inhouse packed C18 analytical column (Magic C18 particles, 3 appended with the alternative translational products using the Andromeda search engine. 78 The following settings were applied: trypsin (specificity set as C-terminal to arginine and lysine) with up to two missed cleavages, mass tolerances set to 20 ppm for the first search and 4.5 ppm for the second search. Methionine oxidation and N-terminal acetylation were chosen as dynamic modifications and carbamidomethylation of cysteine and TMT labeling of peptide N-termini and lysine residues were set as static modifications. The minimum peptide length was set to seven amino acids. False discovery rates (FDR) were set to 1% on peptide and protein levels as determined by reverse database search. Peptide identification was performed with an allowed initial precursor mass deviation up to 7 ppm and an allowed fragment mass deviation of 20 ppm.
For all other search parameters, the default settings were used.
Code
Scripts used for sequencing data processing as well as R codes used for downstream analyses are available upon request. . The test and control plasmids were transfected into delayed brain tumor (DBT) glioblastoma cell cultures. After 48 hrs, the two luciferase activities were quantified using the Dual-Luciferase Assay System and GloMax Luminometer with dual injectors (Promega) following manufacturer's instructions. Readthrough rate was calculated as described 87 and as follows:
Dual luciferase assay
(Firefly activity/ Renilla activity)test (Firefly activity/ Renilla activity) + Ct X 100
Immunofluorescence staining
Brain sections, except for those from mice with MCA occlusion, were collected and processed Brain sections from mice with MCA occlusion were prepared as follows. After transcardial perfusion and overnight fixation as above, the brains were sliced at 1.5 mm, washed with cold PBS for 1 hr and then dehydrated in a series of ethanol concentrations (50%, 70%, 80%, 95%, 100%, 100%, and 100%, each for 1.5 h). After clearing twice with xylene and vacuum-infiltering twice with 58 0 C paraffin, each time for 1 hr, slices were aligned in molds containing 58C paraffin and embedded in the same paraffin letting the paraffin cool down.
Sections were made at 7 um, collected on charged slides, and dried overnight. For staining, slides were first rehydrated by treating in Xylene (3 X 5m, 3 times), 100% ethanol (2 X 10m) times), 95% ethanol (1 X 5m), 80% (1 X 5m), 70% (1 X 5m), 50% (1 X 5m) and distilled water (2 X 5m). Antigen unmasking was then performed by dipping the slides 99 0 C 10 mM sodim citrate buffer and letting the buffer cool down on bench top for 30m. Slides were then washed 2 X 5m
with PBST, and then blocked and stained as described for floating sections above.
Staining of coverslip cultures were done as described previously 39 . Processing and staining of the retinas and kidneys were done as described for floating brain sections above, except that 14 um-thick sections were collected on charged slides.
Primary antibodies and dilutions were: mouse anti-V5 (Sigma, V8012, 1:1000), mouse anti-GFAP (Biogenex, MU020-UC, 1:1000), rabbit anti-cMyc (Sigma, C3956, 1:100), mouse anti-cMyc (Santa Cruz, 9E10, 1:100), goat anti-AQP4 (Santa Cruz, SC-9888, 1:100), rat anti-PECAM-1 (BD Pharmigen, 550274, 1:50), and rabbit anti-AQP4X (made in collaboration with
Cell Signaling Technology,1:1000). The anti-AQP4X was a polyclonal antibody generated by immunizing rabbits with a synthetic peptide corresponding to residues surrounding Asp333 of mouse AQPX and purifying the antibody with protein A and peptide affinity chromatography.
Western blot
Mice were euthanized, and their brains were rapidly homogenized on ice in RIPA buffer (50 mM 
AAV preparation and intracranial injection
The Aqp4 cDNA with a 5' cMyc tag and an extra stop codon beyond the first stop codon and CFP cDNA with a 5' cMyc tag were cloned into pAAV-GFAP-EGFP after removing the EGFP with AgeI and HindIII. The vectors were packaged into AAV9 by the Hope Center Viral Vector
Core at Washington University. Two uL of the viruses were intracranially injected into P1 (AAV9-GFAP-cMyc-Aqp4) or P90 (for AAV9-GFAP-cMyc-CFP) mice. After 3 weeks, the mice were processed for floating brain section immunofluorescence as described above.
tMCAO tMCAO was performed as described previously 88 . Briefly, adult C57Bl/6 mice were anesthetized with isoflurane, and the left common carotid artery (CCA) was exposed through a midline cervical incision. A 6.0-gauge nylon suture coated with silicone was inserted in the CCA lumen and advanced through the internal carotid artery to the origin of the MCA. Interruption of the blood flow in the MCA territory was confirmed with laser Doppler. After 60 m, the suture was withdrawn, and the reperfusion of the MCA territory was confirmed by inspection with an operating microscope and more distally by laser Doppler. After the procedure, animals recovered in an incubator before returning to home cages. The brains were harvested after 24 h and processed for immunofluorescence staining as mentioned above. 
